PJP holdings and overlap

Invesco Pharmaceuticals ETF (PJP) holds 27 positions in its Invesco file of 2026-10-24. Its three largest are AbbVie (ABBV) at 6.00%, Pfizer (PFE) at 5.83% and Gilead Sciences (GILD) at 5.82%, and its ten largest make up 51.5% of the fund.

In its Invesco file of 2026-10-24, PJP is 99.9% health care by sector, with none of it in mega-cap tech or in the ten largest US companies by market value.

View as Markdown What changed
Connect your agent Copies a setup prompt
PJPInvesco Pharmaceuticals ETFHealth Care, Invesco, 27 positions
Last close, 2026-10-28
$126.67 +0.25%
52-week range 95 to 132
Largest position
6.0% of the ETF, AbbVie
Positions
27
51.5% in the ten largest
Cost per year
0.58%
$58 a year on $10,000
Assets
$0.6B
under management
Return, 3 years
+84.0%
cumulative, total return
Worst fall
-14.2%
peak to trough, 3 years, weekly closes

What does PJP hold, as of its issuer file of 2026-10-24?

PJP spreads its weight across 27 positions, against a median of 61 across the 28 Health Care funds with a page here. The position PJP carries furthest above that group is Pfizer at 5.83% of the fund, a company the median fund in that group does not hold at all.

RankCompanyWeightWeight bar
1 ABBV AbbVie 6.0%
2 PFE Pfizer 5.83%
3 GILD Gilead Sciences 5.82%
4 LLY Eli Lilly 5.72%
5 AMGN Amgen 5.49%
6 JNJ Johnson & Johnson 5.36%
7 MRK Merck 5.15%
8 ABT Abbott Laboratories 4.97%
9 AMRX Amneal Pharmaceuticals 3.6%
10 BIIB Biogen 3.59%
11 UTHR United Therapeutics Corp 3.58%
12 PRGO Perrigo 3.48%
13 LGND Ligand Pharmaceuticals 3.41%
14 VTRS Viatris 3.4%
15 INVA Innoviva 3.08%
16 REGN Regeneron Pharmaceuticals 3.05%
17 ANIP ANI Pharmaceuticals 3.03%
18 TARS Tarsus Pharmaceuticals 3.02%
19 PBH Prestige Consumer Healthcare 2.94%
20 HRMY Harmony Biosciences 2.93%
21 BMY Bristol Myers Squibb 2.89%
22 COLL Collegium Pharmaceutical 2.64%
23 JAZZ Jazz Pharmaceuticals 2.6%
24 TVTX Travere Therapeutics 2.36%
25 CORT Corcept Therapeutics 2.2%
26 LQDA Liquidia 1.91%
27 OCUL Ocular Therapeutix 1.89%

The most recent file Invesco has published for PJP is dated 2026-10-24, 4 days before these prices, which is the median for the Invesco ETFs covered here. Every one of the 27 positions PJP holds, with its weight, is in the fund's JSON file. See the other 114 ETFs with a page here that hold ABBV, and how their weights compare with the 6.0% PJP gives it.

Category: Health Care, set by TickerInside from the ETF's own latest file. In its file of 2026-10-24, 100% of its stocks whose sector is known are health care companies, each in the sector the site gives that company. How categories are set.

Use this data
JSONhttps://tickerinside.com/api/v1/fund/pjp.json
CSVhttps://tickerinside.com/api/v1/fund/pjp.csv
Sheets=IMPORTDATA("https://tickerinside.com/api/v1/fund/pjp.csv")If your sheet uses a decimal comma: =IMPORTDATA("https://tickerinside.com/api/v1/fund/pjp.csv"; ","; "en_US")
curlcurl -s https://tickerinside.com/api/v1/fund/pjp.json
API reference · spreadsheet guide Add TickerInside to Claude to ask about PJP with this data

How much money went into or out of PJP?

On the close of Friday, October 23, 2026, PJP neither created nor redeemed shares. Over its last 5 closes, a net outflow of $2.5 million.

PJP's money flows on its last 14 closes, 30 Sep 2026 to 23 Oct 2026, largest inflow $1.2 million on 30 Sep 2026, largest outflow $2.5 million on 16 Oct 2026
2026-09-302026-10-23

From PJP's own holdings files. Every ETF's latest flows.

How is PJP split by sector?

SectorWeightWeight bar
Health care99.9%

From its Invesco file of 2026-10-24. How these are measured.

What did PJP hold in its SEC reports since 2019?

In PJP's SEC filings, its largest position went from AbbVie (ABBV) at 5.65% on 2019-10-31 to Abbott Laboratories (ABT) at 5.67% on 2026-07-31, across 28 quarterly reports.

Largest in 2019
5.65% on 2019-10-31
Largest in 2026
5.67% on 2026-07-31
Ten largest
49.5%
45.9% in 2019
Quarterly reports
28
since 2019, SEC Form N-PORT
ReportPositionsLargestTop 10
2019-10-3129ABBV 5.65%45.9%
2020-10-3129ABT 5.04%47.1%
2021-10-3122MRK 6.99%57.1%
2022-10-3124GILD 6.80%56.2%
2023-10-3124GILD 6.57%55.8%
2024-10-3125ABBV 5.86%50.4%
2025-10-3130LLY 5.50%47.8%
2026-07-3128ABT 5.67%49.5%

The first report, then the last of each year, of the 28 reports PJP filed on SEC Form N-PORT from 2019-10-31 to 2026-07-31, each company under its ticker today. Every position of every report is in its quarterly file, and at any date at /api/v1/history/pjp/{date}.json. How these are read.

What does PJP share with other ETFs?

The ETF nearest to PJP is IYH: the two hold 38.6% of their weight in common, in the 15 companies both own, and 65.7% of PJP itself is also held there. No covered ETF holds more than that in common with PJP; it duplicates nothing here closely.

ETFOverlap by weightOf PJP held thereOf that ETF in PJPCompanies in bothOverlap bar
IYH 38.6% 65.7% 54.3% 15
XLV 38.4% 57.3% 55.2% 12
XPH 37.0% 65.1% 37.0% 19
IHE 36.8% 65.1% 76.3% 19
VHT 36.6% 100.0% 48.3% 27
IXJ 32.7% 57.3% 39.5% 12
PPH 29.9% 42.6% 51.0% 10
BMED 24.9% 45.1% 26.6% 9
IBBQ 22.7% 53.5% 30.8% 16
PBE 22.2% 24.2% 26.1% 6
BBH 20.8% 21.5% 40.7% 5
CANC 20.6% 39.5% 21.2% 8

The holdings of VHT and CANC are from their SEC Form N-PORT filings for the period ended 2026-05-31, filed 2026-07-29. The holdings of PPH and BBH are from their SEC Form N-PORT filings for the period ended 2026-06-30, filed 2026-08-26. The other ETFs' holdings are from their issuers' latest files. Check PJP against any ETF in the ETF overlap calculator · how overlap is measured.

What adds something different to PJP?

SOXX shares 0% of weight with PJP and its weekly returns correlate with it at 0.18 over three years. The table lists the covered ETFs with the least in common with PJP, least shared weight first and, among equals, lowest correlation.

Cost, returns and risk

Expense ratio0.58%
Dividend yield0.92%
Total return, 1 year32.0%
Total return, 3 years cumulative84.0%
Total return, 5 years cumulative66.0%
Volatility, annualised15.8%
Worst fall, 3 years-14.2%
Beta against SPY, 3 years of weekly returns0.5
Weight in the ten largest positions51.5%
Largest single position6.0%
Assets under management$0.6B

Expense ratio, yield and assets are reference data (the expense ratio from PJP's SEC filing of 2026-08-27); the weight in the ten largest positions and the largest single position are from the issuer file of 2026-10-24; every other figure is computed here from weekly closes.

How it moves with the market

AgainstCorrelation, 3 yearsCovariance, annualised, in percent squared
SPY0.43loosely linked95
QQQ0.27barely linked83

Weekly total returns. What the bands mean · why the covariance is printed.

Year by year

YearTotal return
202622.1%
202528.0%
20249.6%
2023-2.2%
2022-2.2%

One year

PJP 132 SPY 116
2025-11-072026-10-30
PJP rebased to 100 a year ago, weekly closes, prices through 2026-10-28.

Where to go next

Holdings from the most recent file Invesco has published, dated 2026-10-24. Prices through 2026-10-28. How every figure here is produced. Measurements, not investment advice.

Cite this page

TickerInside, Invesco Pharmaceuticals ETF (PJP), holdings from the issuer's file of 2026-10-24, https://tickerinside.com/etf/pjp/, CC BY 4.0

<a href="https://tickerinside.com/etf/pjp/">TickerInside</a> (https://tickerinside.com/etf/pjp/)